Trade Report: The Cantel Medical Corp. (CMN) CAO Steven C. Anaya Sold 5,500 Shares

The Cantel Medical Corp. (CMN) CAO Steven C. Anaya Sold 5,500 Shares

Cantel Medical Corp. (NYSE:CMN) CAO Steven C. Anaya sold 5,500 shares of Cantel Medical Corp. stock in a transaction dated Monday, October 10th. The shares were sold at an average price of $77.07, for a total value of $423,885.00. Following the completion of the sale, the chief accounting officer now owns 48,132 shares of the company’s stock, valued at approximately $3,709,533.24. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of Cantel Medical Corp. (NYSE:CMN) opened at 76.88 on Thursday. The stock’s 50 day moving average price is $77.65 and its 200-day moving average price is $71.18. The stock has a market cap of $3.18 billion, a PE ratio of 53.46 and a beta of 1.59. Cantel Medical Corp. has a one year low of $53.64 and a one year high of $81.63.

Cantel Medical Corp. (NYSE:CMN) last announced its quarterly earnings data on Thursday, September 29th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.11. The firm earned $179 million during the quarter. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The firm’s revenue was up 18.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.39 earnings per share. On average, equities analysts predict that Cantel Medical Corp. will post $1.98 earnings per share for the current fiscal year.

A number of analysts have recently issued reports on the company. Benchmark Co. set a $83.00 target price on Cantel Medical Corp. and gave the stock a “buy” rating in a report on Saturday, October 1st. Needham & Company LLC assumed coverage on Cantel Medical Corp. in a report on Wednesday, August 24th. They set a “hold” rating for the company.

Large investors have recently made changes to their positions in the company. LS Investment Advisors LLC increased its stake in shares of Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock valued at $104,000 after buying an additional 106 shares in the last quarter. ProShare Advisors LLC increased its stake in shares of Cantel Medical Corp. by 3.2% in the second quarter. ProShare Advisors LLC now owns 5,186 shares of the company’s stock valued at $356,000 after buying an additional 160 shares in the last quarter. UBS Asset Management Americas Inc. increased its stake in shares of Cantel Medical Corp. by 0.7% in the second quarter. UBS Asset Management Americas Inc. now owns 23,099 shares of the company’s stock valued at $1,588,000 after buying an additional 163 shares in the last quarter. PineBridge Investments L.P. increased its stake in shares of Cantel Medical Corp. by 3.8% in the second quarter. PineBridge Investments L.P. now owns 4,548 shares of the company’s stock valued at $312,000 after buying an additional 165 shares in the last quarter. Finally, Arizona State Retirement System increased its stake in shares of Cantel Medical Corp. by 1.1% in the second quarter. Arizona State Retirement System now owns 18,647 shares of the company’s stock valued at $1,282,000 after buying an additional 200 shares in the last quarter. 81.60% of the stock is owned by hedge funds and other institutional investors.

Cantel Medical Corp. Company Profile

Related posts

Leave a Comment